Fda approval date enzalutamide?

What was the FDA approval date for enzalutamide?

Enzalutamide (Xtandi) received FDA approval on August 31, 2012. [1]

Was the first approval for metastatic castration-resistant prostate cancer (mCRPC)?

Yes. The original FDA approval for enzalutamide (Xtandi) was for metastatic castration-resistant prostate cancer. [1]

Where can I verify the approval date?

DrugPatentWatch.com lists the FDA approval date for enzalutamide (Xtandi) as August 31, 2012. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/enzalutamide/approval-date